Javascript must be enabled to continue!
Possible Gatifloxacin-Induced Hypoglycemia
View through CrossRef
OBJECTIVE:
To report a case of hypoglycemia in a patient receiving gatifloxacin for presumed exacerbation of chronic obstructive pulmonary disease (COPD).
CASE SUMMARY:
A 73-year-old white man with an extensive past medical history significant for type 2 diabetes mellitus and COPD was prescribed gatifloxacin 400 mg/d for a COPD exacerbation. After 2 days of therapy, the patient presented to the emergency department (ED) reporting worsening symptoms; he had a blood glucose concentration of 22 mg/dL. Because he had not eaten well for several days, the patient discontinued his oral antidiabetic medications prior to presenting to the ED, but continued to take gatifloxacin. The patient had never before experienced a symptomatic hypoglycemic episode during the years of taking his antidiabetic medications. In the ED, he received 1 last dose of gatifloxacin and was treated aggressively with intravenous dextrose. By the end of his hospitalization, antidiabetic medication was restarted to control hyperglycemia.
DISCUSSION:
Although gatifloxacin has been shown to alter glucose homeostasis, the mechanism of action has not been elucidated. Other recognized risk factors that contribute to the development of hypoglycemia are discussed. Our patient experienced hypoglycemia after receiving gatifloxacin and recovered 24 hours after discontinuation. The Naranjo probability scale suggests a possible drug-related event.
CONCLUSIONS:
The temporal relationship of gatifloxacin administration and the hypoglycemic episode suggests that gatifloxacin likely precipitated the event. Clinicians should be aware of this adverse effect in patients taking gatifloxacin presenting with hypoglycemia.
Title: Possible Gatifloxacin-Induced Hypoglycemia
Description:
OBJECTIVE:
To report a case of hypoglycemia in a patient receiving gatifloxacin for presumed exacerbation of chronic obstructive pulmonary disease (COPD).
CASE SUMMARY:
A 73-year-old white man with an extensive past medical history significant for type 2 diabetes mellitus and COPD was prescribed gatifloxacin 400 mg/d for a COPD exacerbation.
After 2 days of therapy, the patient presented to the emergency department (ED) reporting worsening symptoms; he had a blood glucose concentration of 22 mg/dL.
Because he had not eaten well for several days, the patient discontinued his oral antidiabetic medications prior to presenting to the ED, but continued to take gatifloxacin.
The patient had never before experienced a symptomatic hypoglycemic episode during the years of taking his antidiabetic medications.
In the ED, he received 1 last dose of gatifloxacin and was treated aggressively with intravenous dextrose.
By the end of his hospitalization, antidiabetic medication was restarted to control hyperglycemia.
DISCUSSION:
Although gatifloxacin has been shown to alter glucose homeostasis, the mechanism of action has not been elucidated.
Other recognized risk factors that contribute to the development of hypoglycemia are discussed.
Our patient experienced hypoglycemia after receiving gatifloxacin and recovered 24 hours after discontinuation.
The Naranjo probability scale suggests a possible drug-related event.
CONCLUSIONS:
The temporal relationship of gatifloxacin administration and the hypoglycemic episode suggests that gatifloxacin likely precipitated the event.
Clinicians should be aware of this adverse effect in patients taking gatifloxacin presenting with hypoglycemia.
Related Results
Ghrelin does not impact the blunted counterregulatory response to recurrent hypoglycemia in mice
Ghrelin does not impact the blunted counterregulatory response to recurrent hypoglycemia in mice
IntroductionRecurrent episodes of insulin-induced hypoglycemia in patients with diabetes mellitus can result in hypoglycemia-associated autonomic failure (HAAF), which is character...
Hypoglycemia Subtypes in Type 1 Diabetes: An Exploration of the Hypoglycemia Fear Survey-II
Hypoglycemia Subtypes in Type 1 Diabetes: An Exploration of the Hypoglycemia Fear Survey-II
<i>Objectives: </i>The Hypoglycemia Fear Survey II (HFS-II) is a
well-validated measure of fear of hypoglycemia in people with type 1
diabetes. The aim of this study w...
Hypoglycemia Subtypes in Type 1 Diabetes: An Exploration of the Hypoglycemia Fear Survey-II
Hypoglycemia Subtypes in Type 1 Diabetes: An Exploration of the Hypoglycemia Fear Survey-II
<i>Objectives: </i>The Hypoglycemia Fear Survey II (HFS-II) is a
well-validated measure of fear of hypoglycemia in people with type 1
diabetes. The aim of this study w...
Hypoglycemia
Hypoglycemia
AbstractIatrogenic hypoglycemia often causes recurrent morbidity and precludes maintenance of lifelong euglycemia in people with diabetes mellitus. It causes an array of neurogenic...
Interchangeability of 400‐mg Intravenous and Oral Gatifloxacin in Healthy Adults
Interchangeability of 400‐mg Intravenous and Oral Gatifloxacin in Healthy Adults
Study Objective. To evaluate the interchangeability of 400‐mg intravenous and oral doses of gatifloxacin.Design. Randomized, open‐label, crossover study.Setting. GFI Pharmaceutical...
Two photon microscopic findings of sonoporation‐assisted enhancement of corneal penetration of fluoroquinolone antibiotics
Two photon microscopic findings of sonoporation‐assisted enhancement of corneal penetration of fluoroquinolone antibiotics
PurposeTo investigate the sonoporation‐assisted enhancement of corneal penetration of fluoroquinolone antibiotics.MethodsEnucleated mouse corneas were imaged by two‐photon microsco...
Severe Hypoglycemia in Children With IDDM: A prospective population study, 1992–1994
Severe Hypoglycemia in Children With IDDM: A prospective population study, 1992–1994
OBJECTIVE
Is an increased incidence of severe hypoglycemia an unavoidable effect of improved metabolic control? And, if so, to what extent?
...
Effect of recurrent severe insulin-induced hypoglycemia on the cognitive function and brain oxidative status in the rats
Effect of recurrent severe insulin-induced hypoglycemia on the cognitive function and brain oxidative status in the rats
Abstract
Background
Episodes of recurrent or severe hypoglycemia can occur in patients with diabetes mellitus, insulinoma, neonatal hypoglycemia, an...

